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ABSTRACT
Background and Objective: Genetic studies on gestational diabetes (GDM) are relatively scarce; moreover,
limited data is available for KCNQ1 polymorphism in Pakistani pregnant women. We aimed to determine
the frequency of KCNQ1 rs2237895 in GDM and normal pregnant controls and its association with GDMrelated phenotypes.
Methods: A total of 637 pregnant females (429 controls and 208 cases) in their second trimester were
classified according to the International Association of the Diabetes and Pregnancy Study criteria in
this study. Their blood samples were genotyped for KCNQ1 SNP rs2237895 using PCR-RFLP method and
sequencing. Fasting and two hour-post glucose load blood levels, serum HbA1c, insulin, and anthropometric
assessment was performed. Pearson’s Chi Square test, Mann- Whitney U test, and regression analyses were
performed. A p-value of <0.05 was considered significant.
Results: The variant genotyped was in Hardy-Weinberg equilibrium (p>0.05). The rs2237895 showed an
association with GDM (OR 2.281; 1.388-3.746: p <0.001) and remained significant after multiple adjustments
for age and body mass index (OR 2.068; 1.430-2.997: p=0.005). The C allele showed positive association
with insulin level, and HOMA-IR in study subjects.
Conclusions: This study identifies that KCNQ1 rs2237895 polymorphisms might be associated with risk of
GDM in Pakistani population and that it is related to higher glucose levels and insulin resistance. Further
large scale studies are required to consolidate on the functional aspect of this polymorphism.
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INTRODUCTION
Gestational diabetes mellitus (GDM) is defined
as glucose intolerance that first occurs or is first
identified during pregnancy.1 Although the
true prevalence of GDM is unknown, a 16–27%
prevalence is reported worldwide,2 whereas, 8%
pregnant females suffer from GDM in Pakistan.3-5
GDM not only increases the likelihood of several
maternal and perinatal complications including
delivery by cesarean section, neonatal hypoglycemia
and adiposity, but women with GDM and their
offspring are also at an increased risk of developing
diabetes later in life.5 GDM has many etiological
factors and till date a particular pathophysiological
mechanism singularly responsible is unidentified.
The genome wide association studies have
identified various susceptibility genes, including
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several type 2 diabetes mellitus (T2DM) such as
PPARG, TCF7L2, FTO, CDKN2A/2B, and IRS1 etc.
to be associated with the risk of T2DM, though their
definite relation with GDM remains to be explored
further.6,7
Recently, KCNQ1 (potassium voltage gated
channel, KQT-like subfamily, member1) was added
to the candidate genes conferring susceptibility to
T2DM.8 KCNQ1 is located at chromosome 11p15.5,
and encodes the pore-forming potassium (K+)
channel alpha-subunit. It is expressed in the heart,
inner ear, stomach, small and large intestine, liver,
kidney, adipose tissue and the pancreas. So far its
role is well researched in the pathogenesis of long
QT syndrome and atrial fibrillation,9 where it is
responsible for encoding a voltage-gated potassium
channel required for the repolarization phase of the
cardiac action potential.10
Insulin release from beta cells (ß) of pancreases
is controlled by intricate interaction between
ATP-sensitive potassium (KATP) channels,
voltage-dependent potassium (Kv) channels and
voltage-dependent calcium channels.11,12 KCNQ1
is responsible for membrane repolarization of
pancreatic ß cell, leading to cessation of calcium
influx and subsequently insulin secretion.
Mutations in this channel may be responsible for
premature termination of calcium influx which
leads to decreased insulin secretion in patients with
T2DM and GDM.11,12
A strong association between KCNQ1
polymorphisms and T2DM is reported both in
the East Asian and European populations.13,14
The single-nucleotide polymorphisms (SNPs)
reported has the second largest effect size next to
TCF7L2. The following SNP (rs2237897, rs2283228,
rs2237895, rs2074196 and rs2237892) of this gene
have recently been shown to confer susceptibility to
T2DM. In addition, the risk allele of rs2237892 was
associated with impaired insulin secretion, which
may be intermediated through an effect on beta
cell function,15,16 whereas the C alleles of rs2237892
and rs2237895 were found to be associated with
increased risk of GDM in Korean population.17
Besides these favorable results, uncertainty exists
about their association with GDM or its related
phenotypes. Thus, we aimed to investigate the
association of common genetic polymorphism
of KCNQ1 rs2237895 in gestational diabetic and
normal pregnant controls. In addition, this SNP
was examined for its possible association with
GDM-related clinical phenotypes.

METHODS
Late second trimester pregnant women from the
antenatal care clinics of Aga Khan University and
Abassi Shaheed Hospital in Karachi, Pakistan were
enrolled in this case-control study. The investigation
was carried out between February 2014 and
February 2016. The institutional ethics committee
approved the research protocol; written informed
consent was obtained from all participants.
A total of 637 pregnant females were recruited
by employing convenience random sampling
technique for this case-control study. This sample
size was considered sufficient to achieve 80%
power and detect an odds ratio of at least 2 among
GDM women. The two sided level of significance
was set at 5% as calculated by NCSS/PASS version
11 software for power analysis and sample size.18
The study group included 208 pregnant women
diagnosed with gestational diabetes (GDM case)
according to the Glucose Tolerance Test (GTT)
criteria proposed by the International Association
of Diabetes and Pregnancy Study Group (IADPSG)
i.e. a fasting glucose ≥92 mg/dL and/or 1 h: ≥180
mg/dL (10.0 mmol/L) and/or 2 h: ≥153 mg/
dL (8.5 mmol/L) (when any of the following
plasma glucose values are exceeded, the subject
is considered as having GDM). The control group
included 429 normo-glycemic pregnant women,
with blood glucose levels below the above
mentioned criteria. All study subjects (whether
case or control) were excluded if they had diabetes
before pregnancy or developed diabetes before 24
weeks of gestation, impaired fasting glucose or
impaired glucose tolerance, history of hypertension,
twin pregnancies, taking hormonal support or any
condition affecting the maternal fetal health.
The weight at booking and anthropometric
measurements of all participants was recorded
from the patient record cards, while current weight
of subjects was measured in kilogram on a digital
weighing scale in light clothing without shoes (with
an accuracy of ±100g) while body mass index (BMI)
was calculated.
Ten ml of venous blood was collected. Serum was
obtained after centrifugation of blood samples and
was immediately frozen at -80 C till further analyzed.
Serum Insulin was measured using commercially
available ELISA assay (cat# KAP1251, DIA source
Immuno Assay S.A., Belgium), while insulin
resistance (HOMA-IR= Glucose (mg/dl) X Insulin
(µIU/ml)/405) and insulin sensitivity (QUICKI =1/
Log (fasting insulin μIU/ml) + log (fasting glucose
mg/dl) were calculated.
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DNA was extracted from whole blood as
per the vendor’s instruction by commercially
available Qiagen DNA extraction kit (Cat. number
51185, Valencia, CA, USA). The quantification of
extracted DNA was performed by measuring the
UV absorbance of the samples using a NanodropND1000 (Thermo Fisher Scientific, Waltham, MA).
A ratio of ~1.8 was considered acceptable for
confirming the purity of extracted DNA.

Primers were designed using NCBI primer
designing tool for KCNQ1 rs2237895 (Forward
CTCAGCCTGCAGTGTCCAGG; Reverse AAGGGACAGAGCTGCTCCCAA). Polymerase chain
reaction (PCR) was performed using the Ruby Taq
PCR Master mix 2X (cat# 71191, Affymetrix, USA)
as per the manufacturer’s instructions. The amplicons were digested with restriction enzyme SmaI
(Cat #R0141L, New England Biolabs, USA) accord-

Fig.1 (A-C): Gel Electrophoresis and Sequencing Chromatogram of KCNQ1 SNPs. Where M is the 50bp DNA marker and
B are negative controls in the PCR reaction. A: PCR amplification shown as bands on 2% agarose gel for rs2237895 (218bp)
samples numbered 1-4. B: RFLP fragment [3 homozygous mutated: 140bp/78bp (C/C) for samples number 1, 3 & 4; 1
heterozygous carrier: 218bp/140bp/78bp (A/C)] for sample numbered 2 respectively. C: Sequencing Chromatograms
showing the mutations as dot and highlighted section in the aligned sequence.
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ing to the standard instructions of the manufacturer. The digested fragments were electrophoresed in
2% Agarose gel.
Genotypes were scored by an independent person, who was blinded about the case control status
of the study subjects. In the additive model, genotype of non-risk allele homozygote (C/C), heterozygote (A/C) and risk allele homozygote (A/A) were
coded as 0, 1 and 2 respectively. Further, negative
controls were placed in duplicates in each run, to
ensure correct genotyping. Overall call rate for genotype data was >97%. A genotyping quality control
was performed in 50% of the samples by duplicate
checking (rate of concordance in duplicates was
>99%). Further reconfirmations of genotyping accuracy were made by sequencing 20% of the samples
with detected polymorphic variants (discrepancy
rate was <0.20%) (ABI3730XL, automated DNA sequencer, Macrogen, Korea) (Fig.1).
Statistical Analysis: Statistical analyses were
conducted using the IBM Statistical Package for the
Social Sciences (IBM SPSS version 21; IBM Corp Inc,
Armonk, NY). Descriptive analysis of categorical
data was presented in terms of frequencies and
percentages whereas that for continuous variables
was expressed as mean ± standard deviation. Mann
Whitney U test and Pearson chi‑square test of
independence were used for comparing continuous
and categorical variables wherever applicable.
Hardy–Weinberg
equilibrium
(HWE)
was
calculated for SNP data. SNP data was analysed
for genotype and allele frequency determination by
applying chi-squared statistics. Significance of risk
allele with study parameters was determined with
regression analyses. Genotypes were allotted code
of 0/1/2 rendering the number of minor alleles
under an additive model of inheritance.

Table-I: Clinical and biochemical data
of cases and controls.
Variables

Control n=429

Case n=208

Mean ± S.D

Mean ± S.D

Age (in year)
25.97 ± 4.87
27.31± 5.56
Weight at Booking (kg) 57.55 ± 10.15
63.84± 12.58**
24.83 ± 5.13**
BMI at Booking (kg/m2) 22.77 ± 4.19
GTT 0 hr (mg/dl)
78.69 ± 8.96 106.23 ± 20.70 **
GTT 2 hr (mg/dl)
124.22 ± 11.94 177.33 ± 45.57**
HbA1c (%)
N.A
5.79 ± 1.43
Insulin (IU/mL)
13.28 ± 5.26
37.08 ± 7.66**
BMI (body mass index), GTT (glucose tolerance test).
Values expressed as Mean ± SD. Groups compared by
Mann Whitney U test for continuous data. **p<0.01

a higher BMI, pre and post load GTT, HBA1c and
insulin levels (p<0.01) when compared to pregnant
controls (Table-I).
Genotype and allele frequencies of the study
subjects are given in Table-II. The genotyped variant
showed a strong association with GDM (p<0.001).
The rs2237895 C allele depicted a significant risk
association with GDM (p<0.001).
Further, regression analysis was performed on
unadjusted genotypes and after adjusting with
risk factors such as age and pre pregnancy BMI. A
significant association was observed with GDM (OR
2.281; p = 0.0002), which remained independently
linked with GDM risk (OR 2.068; p=0.005) even
after multiple comparison under additive model
(Table-III).
We also investigated the association of KCNQ1
variant with quantitative traits associated with
obesity and glucose homeostasis in the study
cohort. Linear regression analysis revealed a
moderately significant association of ‘C’ allele with
insulin levels (β = -0.238 p = 0.0007), HbA1c (β =
-0.123 p< 0.001) while weak association were seen
with HOMA-IR (β = -0.021 p< 0.001) and fasting
blood glucose (β = -0.043 p< 0.001).

RESULTS
Six hundred and thirty-seven pregnant females
were recruited in this study. The GDM group had

Table-II: Genotypes and Allele Frequencies of KCNQ1 rs2237895 polymorphism.
Genotype

Control (n=429) Case (n=208)

P value

Allele

Group

rs2237895					
AA
175 (40.8)
51 (24.5)
<0.001
C
AC
188 (43.8)
114 (54.8)			
CC
66 (15.4)
43 (20.7)		
A
					

Control
Case
Control
Case

Allele Data
Frequency n (%)

OR (95%CI)

320 (37.50)
1.557 (1.228-1.973)
216 (51.92)		
538 (62.50)		
200 (48.08)		

P value
< 0.001

Genotype AA: homozygous dominant; AC: heterozygous mutated; CC: homozygous mutated.
A is the major allele and C is the minor allele. Frequencies are given as absolute values with percentage given in
parenthesis. The Hardy Weinberg Equilibrium (HWE) stats for the study cohort was > 0.05
P value <0.05 calculated by Pearson’s x2 square test.
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Table-III: Association of KCNQ1 SNP with GDM assessed under Additive model.
Unadjusted Odds Ratio

Adjusted for Age and BMI

Genotype

Odds Ratios

95.0% C.I Odds Ratio

Odds Ratios

95.0% C.I Odds Ratio

rs2237895

2.281**

1.388-3.746

2.068*

1.430-2.991

*OR with p<0.05 considered as significant; **OR with p<0.001.

DISCUSSION
There are many proposed theories such as
polymorphisms in PPAR2, IGF2BP2, CDKL1 and
CDKN2a in the quest to find a link between genetic
factors and GDM.7 Many studies have linked T2DM
with polymorphisms in KCNQ1 gene.16,11,13,19 but
few with GDM. We focused on rs2237895 SNP in
the KCNQ1 gene which is known to be a susceptible
T2DM candidate gene, and it showed a possible
sound association with GDM in our study (Table
II and III). Our findings are in line with the initial
data on the link between KCNQ1 and GDM which
came through studies done in Korean population.
It was reported that the C allele of rs2237895 was
associated with increased risk of GDM (OR=1.24;
p=0.005).6,20,21 Similar results to our study were
found in a Chinese population.22 We also report
a risk allele frequency of 52% in GDM positive
females, which is somewhat close to the risk allele
frequency of 45% reported in Indian Punjabis with
T2DM,13 35% in Chinese females with GDM,22 33%
in Korean GDM females20 and 34.5% in Chinese
subjects with T2DM.23
Similarly, the minor allele frequency reported
in our study was 37.5% in our control population
(Table-II), which is close to a previously published
result of 42%.13 The difference in frequencies reported
could be due to a different set of ethnic population at
a different geographic location tested. A moderately
significant association of ‘C’ allele with insulin levels,
HbA1c, insulin resistance and fasting glucose levels
was observed in our study similar to a previous
report.13 Additionally, in two recent related studies
for Pakistani population it was reported that SNPs
in or near PPARG, TCF7L2, FTO, CDKN2A/2B,
and KCNQ1 may have potential associations with
T2DM, with similar effect sizes to those seen in
European populations.6,24 Though, this is an exciting
finding further research is required to establish an
affirmative causal link.
We also observed that both weight and body mass
index (BMI) values were higher in our GDM cases
in comparison to controls (Table-I). Asian’s are
known to have a higher body fat proportion even at
a lower BMI value in comparison to Caucasian’s,26
and this situation might lead to early development
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of adverse effects during pregnancy. Though, we
failed to identify any significant association in
terms of weight and BMI with the minor allele in
our study population. Despite the fact that weight
of the baby is controlled by the anthropometric
measures of the parents’ via genetic bond, mother’s
weight has a supplementary effect, controlling
the intrauterine environment. This suggests that
KCNQ1 polymorphism may not have a direct
impact on the weight status of an individual but act
by other pathways to induce insulin resistance in
GDM and/or T2DM.
The associations between KCNQ1 polymorphisms
and increased risk for GDM not only indicate
similar pathogenic mechanisms with T2DM but
also make KCNQ1 a novel potential therapeutic
target for both T2DM and GDM. Our study was
limited in a way that we were unable to recruit
large number of study participants due to cultural
constraints about genetic studies. More so, we did
not focus on the lifestyle factors or environmental
factors, such as diet and physical activities, which
prevents us from analysing any interaction between
rs2237895 and other factors on GDM. Nevertheless,
the rs2237895 polymorphism was in HWE in the
both groups, suggesting the randomness of subject
selection which is a strength of our study.
CONCLUSION
This study identifies that KCNQ1 rs2237895
polymorphisms might be associated with risk
of GDM in Pakistani population and that it is
related to the higher glucose levels and insulin
resistance. Further large scale studies are required
to consolidate on the functional aspect of this
polymorphism.
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